Abstract

The invention concerns oxadiazole derivatives of general formula (I) in which X, Y, Z and R<1> have the definitions given in the description and the claims. The invention further concerns processes for preparing these substances and their use as medicaments.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (13)

    Publication numberPublication dateAssigneeTitle
    EP-1070708-A1January 24, 2001F. Hoffmann-La Roche AgDérivés de triazole et imidazole
    EP-2053041-A2April 29, 2009Eisai R&D Management Co., Ltd.1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease
    US-6107313-AAugust 22, 2000Combichem, Inc.Dopamine receptor antagonists
    US-6265426-B1July 24, 2001Hoffmann-La Roche Inc.Triazole derivatives
    US-6825192-B1November 30, 2004Eisai Co., Ltd.Heterodiazinone derivatives
    US-6949571-B2September 27, 2005Eisai Co., Ltd.1,2-dihydropyridine compounds, process for preparation of the same and use thereof
    US-7563811-B2July 21, 2009Eisai R&D Management Co., Ltd.1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
    US-7759367-B2July 20, 2010Eisai R&D Management Co., Ltd.Pharmaceutical compositions and their uses
    US-7939549-B2May 10, 2011Eisai R&D Management Co., Ltd.1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
    US-8304548-B2November 06, 2012Eisai R&D Management Co., Ltd.Method for producing 1, 2-dihydropyridine-2-one compound
    US-8772497-B2July 08, 2014Eisai R&D Management Co., Ltd.Method for producing 1, 2-dihydropyridine-2-one compound
    US-9045426-B2June 02, 2015Eisai R&D Management Co., Ltd.Method for producing 1,2-dihydropyridine-2-one compound
    US-9884858-B2February 06, 2018Sumitomo Chemical Company, LimitedDiaryl-azole compound